StocksMediumUpdated•Originally published 19 October 2026•Updated 19 October 2026•
1 min read
City Therapeutics Stock Jumps 19% in Nasdaq Trading Debut
Key Facts
1City Therapeutics raised $230 million in an upsized initial public offering on the Nasdaq.
City Therapeutics shares debuted on the Nasdaq at $23.00, rising 19.2% from the initial public offering price of $18.00. The surge in early trading gave the company a market valuation of $1.19 billion on its first day as a public entity.
The trading debut follows a successful $230 million upsized IPO designed to meet high investor demand. With the stock trading at $23.00 on October 19, 2026, the company plans to utilize the capital raised to fund its ongoing biotech operations.